Stock Updates

Is Valeant Pharmaceuticals International, Inc.(NYSE: VRX), a large market cap stock a smart buy?

With a market cap of has a large market cap size. Valeant Pharmaceuticals International, Inc. (NYSE: VRX) has been on the stock market since its IPO date on the 3/30/1994. Valeant Pharmaceuticals International, Inc. is in the Drug Delivery industry and Healthcare sector. Average volume for Valeant Pharmaceuticals International, Inc., is 29651.8, and so far today it has a volume of 15428300. Performance year to date since the 3/30/1994 is -71.35%.

To help you determine whether Valeant Pharmaceuticals International, Inc. is undervalued the following values will help you decide. P/E is *TBA and forward P/E is 3.78. PEG perhaps more useful shows that Valeant Pharmaceuticals International, Inc. has a value for PEG of *TBA. P/S ratio is 0.97 and the P/B ratio is 1.9. The P/Cash and P/Free cash flow is 11.77 and 7.7 respectively.

At the current price Valeant Pharmaceuticals International, Inc. is trading at, 29.12 (0.31% today), Valeant Pharmaceuticals International, Inc. has a dividend yield of *TBA, and this is covered by a payout ratio of *TBA. Earnings per share (EPS) is -2.86, and this is looking to grow in the next year to 17.94% after growing -133.00% this past year. EPS growth quarter over quarter is *TBA, and -68.30% for sales growth quarter over quarter.

The number of shares outstanding is 344.43, and the number of shares float is 332.63. The senior management bring insider ownership to 2.30%, and institutional ownership is at 66.80%. The float short is 9.93%, with the short ratio at a value of 1.11. Management has seen a return on assets of -2.00%, and also a return on investment of 3.70%.

The ability for Valeant Pharmaceuticals International, Inc., to deal with debt, means it current ratio is 1.4, and quick ratio is 1.1. Long term debt/equity is 5.81 and total debt/equity is 5.87. In terms of margins, Valeant Pharmaceuticals International, Inc. has a gross margin of 74.70%, with its operating margin at 7.70%, and Valeant Pharmaceuticals International, Inc. has a profit margin of -9.60%.

The 52 week high is -88.15%, with 56.98% being its 52 week low. The 20 day simple moving average is 19.09% and the 200 day simple moving average is -44.47%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

 

About the author

Tony Dabbs

Leave a Comment